About Aesculap
Aesculap is a company based in Tuttlingen (Germany) founded in 1867 was acquired by B Braun in June 1996. It operates as a B2B2C and Professional Services. Aesculap offers products and services including Surgical Instruments, Minimally Invasive Surgery, and Orthopaedic Surgery.
- Headquarter Tuttlingen, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name B. Braun Se
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aesculap
Aesculap offers a comprehensive portfolio of products and services, including Surgical Instruments, Minimally Invasive Surgery, and Orthopaedic Surgery.
Surgical instruments are provided for various medical procedures.
Solutions for minimally invasive surgery are offered here.
Orthopaedic surgery solutions are developed for patient care.
Funding Insights of Aesculap
Detailed funding history for Aesculap
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aesculap
Aesculap has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B. Braun.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
B. Braun is recognized as a leading medical technology company.
|
Locked | Locked | Locked |
Investor details for Aesculap
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aesculap
Investment portfolio details for Aesculap
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aesculap
Detailed financials for Aesculap
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aesculap Comparisons
Peer comparison for Aesculap
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aesculap
Detailed competitors of Aesculap
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aesculap
Complete news archive for Aesculap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aesculap
Aesculap was founded in 1867.
Aesculap is headquartered in Tuttlingen, Germany. It is registered at Tuttlingen, Baden-wurttemberg, Germany.
Jean Claude Dubacher is the current CEO of Aesculap.
Aesculap, a key brand under B. Braun SE, is dedicated to providing innovative surgical and interventional solutions. The company is engaged in developing products and services for core surgical processes, including minimally invasive surgery, orthopaedic surgery, and neurosurgery. Solutions are offered across various sectors such as infection prevention, infusion therapy, and wound management. Smart infusion management and surgical asset management are also provided to enhance healthcare delivery. With a presence in multiple therapeutic areas, Aesculap is committed to protecting and improving patient health globally.
Aesculap offers Surgical Instruments, Minimally Invasive Surgery, and Orthopaedic Surgery.
Aesculap has 1 investor. Key investors include B. Braun.